Patents by Inventor Robert S. Jordan

Robert S. Jordan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARTIFICIAL TEARS AND THERAPEUTIC USES
    Publication number: 20240108677
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e. g. olive oil, sesame oil, corn oil etc.
    Type: Application
    Filed: August 3, 2023
    Publication date: April 4, 2024
    Inventors: Anuradha V. Gore, Robert S. Jordan, Kevin Krock, Chetan Pujara
  • MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
    Publication number: 20230241030
    Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.
    Type: Application
    Filed: April 5, 2023
    Publication date: August 3, 2023
    Inventors: Anuradha V. Gore, Kevin S. Warner, Chetan P. Pujara, Richard S. Graham, Ajay P. Parashar, Mu-Lan Lee, Robert S. Jordan, Sukhon Likitlersuang
  • Energy providing devices and applications thereof
    Patent number: 11258134
    Abstract: Disclosed herein are compositions for use in an energy providing devices and methods of preparing such devices. Also included herein is energy providing devices that comprise a charged compound modified substrate or zwitterion-modified substrate or energy providing devices that comprise an electrolyte that comprises a perhalogenatedphenyl azide charged or zwitterionic compound.
    Type: Grant
    Filed: February 19, 2020
    Date of Patent: February 22, 2022
    Assignee: The Regents of the University of California
    Inventors: Brian T. McVerry, Ethan Rao, Robert S. Jordan, Richard B. Kaner
  • Synthesis of graphene nanoribbons from monomeric molecular precursors bearing reactive alkyne moieties
    Patent number: 11247905
    Abstract: A method of forming a graphene nanoribbon includes: 1) providing monomeric precursors each including an alkyne moiety and at least one aromatic moiety bonded to the alkyne moiety; 2) polymerizing the monomeric precursors to form a polymer; and 3) converting the polymer to a graphene nanoribbon.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: February 15, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Yves Rubin, Robert S. Jordan, Yolanda L. Li, Ryan D. McCurdy, Simon Kervyn De Meerendré
  • ARTIFICIAL TEARS AND THERAPEUTIC USES
    Publication number: 20220008496
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e. g. olive oil, sesame oil, corn oil etc.
    Type: Application
    Filed: May 25, 2021
    Publication date: January 13, 2022
    Inventors: Anuradha V. Gore, Robert S. Jordan, Kevin Krock, Chetan Pujara
  • MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
    Publication number: 20210275497
    Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.
    Type: Application
    Filed: March 16, 2021
    Publication date: September 9, 2021
    Inventors: Anuradha V. Gore, Kevin S. Warner, Chetan P. Pujara, Richard S. Graham, Ajay P. Parashar, Mu-Lan Lee, Robert S. Jordan, Sukhon Likitlersuang
  • Artificial tears and therapeutic uses
    Patent number: 11045515
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: June 29, 2021
    Assignee: ALLERGAN, INC.
    Inventors: Anuradha V. Gore, Robert S. Jordan, Kevin Krock, Chetan Pujara
  • ENERGY PROVIDING DEVICES AND APPLICATIONS THEREOF
    Publication number: 20200203692
    Abstract: Disclosed herein are compositions for use in an energy providing devices and methods of preparing such devices. Also included herein is energy providing devices that comprise a charged compound modified substrate or zwitterion-modified substrate or energy providing devices that comprise an electrolyte that comprises a perhalogenatedphenyl azide charged or zwitterionic compound.
    Type: Application
    Filed: February 19, 2020
    Publication date: June 25, 2020
    Inventors: Brian T. McVerry, Ethan Rao, Robert S. Jordan, Richard B. Kaner
  • Energy providing devices and applications thereof
    Patent number: 10629880
    Abstract: Disclosed herein are compositions for use in an energy providing devices and methods of preparing such devices. Also included herein is energy providing devices that comprise a charged compound modified substrate or zwitterion-modified substrate or energy providing devices that comprise an electrolyte that comprises a perhalogenatedphenyl azide charged or zwitterionic compound.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: April 21, 2020
    Assignee: The Regents of the University of California
    Inventors: Brian T. McVerry, Ethan Rao, Robert S. Jordan, Richard B. Kaner
  • SYNTHESIS OF GRAPHENE NANORIBBONS FROM MONOMERIC MOLECULAR PRECURSORS BEARING REACTIVE ALKYNE MOIETIES
    Publication number: 20200055735
    Abstract: A method of forming a graphene nanoribbon includes: 1) providing monomeric precursors each including an alkyne moiety and at least one aromatic moiety bonded to the alkyne moiety; 2) polymerizing the monomeric precursors to form a polymer; and 3) converting the polymer to a graphene nanoribbon.
    Type: Application
    Filed: November 17, 2017
    Publication date: February 20, 2020
    Inventors: Yves RUBIN, Robert S. JORDAN, Yolanda L. LI, Ryan D. MCCURDY, Simon KERVYN DE MEERENDRÉ
  • ARTIFICIAL TEARS AND THERAPEUTIC USES
    Publication number: 20180264063
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e. g. olive oil, sesame oil, corn oil etc.
    Type: Application
    Filed: October 23, 2017
    Publication date: September 20, 2018
    Inventors: Anuradha V. Gore, Robert S. Jordan, Kevin Krock, Chetan Pujara
  • ENERGY PROVIDING DEVICES AND APPLICATIONS THEREOF
    Publication number: 20180159106
    Abstract: Disclosed herein are compositions for use in an energy providing devices and methods of preparing such devices. Also included herein is energy providing devices that comprise a charged compound modified substrate or zwitterion-modified substrate or energy providing devices that comprise an electrolyte that comprises a perhalogenatedphenyl azide charged or zwitterionic compound.
    Type: Application
    Filed: November 30, 2017
    Publication date: June 7, 2018
    Inventors: Brian T. McVerry, Ethan Rao, Robert S. Jordan, Richard B. Kaner
  • Artificial tears and therapeutic uses
    Patent number: 9821020
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: November 21, 2017
    Assignee: ALLERGAN, INC.
    Inventors: Anuradha V. Gore, Robert S. Jordan, Kevin Krock, Chetan Pujara
  • STABILIZED COMPOSITIONS COMPRISING A THERAPEUTICALLY ACTIVE AGENT AND AN OXIDIZING PRESERVATIVE
    Publication number: 20150283240
    Abstract: Citric acid and conjugate bases thereof are useful for stabilizing stabilized chlorine dioxide in the presence of therapeutically active agents and excipients in a composition. Ophthalmic compositions and methods related thereto are also disclosed herein.
    Type: Application
    Filed: April 4, 2014
    Publication date: October 8, 2015
    Applicant: Allergan, Inc.
    Inventors: Robert T. Lyons, Robert S. Jordan
  • Ophthalmic formulations containing substituted gamma lactams and methods for use thereof
    Patent number: 8952051
    Abstract: The invention provides ophthalmic formulations containing well-defined substituted gamma lactams. The formulations described herein are useful in treating a variety of ocular diseases related to ocular hypertension, such as for example, glaucoma.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: February 10, 2015
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Robert S. Jordan, Ajay Parashar, Chetan Pujara, Richard Graham, Mu-Lan Lee
  • MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
    Publication number: 20140287988
    Abstract: Provided herein are compositions, which include an active pharmaceutical ingredient and macrogol 15 hydroxystearate, and methods for using the same for treating diseases or disorder.
    Type: Application
    Filed: December 9, 2013
    Publication date: September 25, 2014
    Applicant: ALLERGAN, INC.
    Inventors: ANURADHA V. GORE, KEVIN S. WARNER, CHETAN P. PUJARA, RICHARD S. GRAHAM, AJAY P. PARASHAR, MU-LAN LEE, ROBERT S. JORDAN, SUKHON LIKITLERSUANG
  • ARTIFICIAL TEARS AND THERAPEUTIC USES
    Publication number: 20140141106
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc.
    Type: Application
    Filed: January 28, 2014
    Publication date: May 22, 2014
    Applicant: ALLERGAN, INC.
    Inventors: ANURADHA V. GORE, ROBERT S. JORDAN, KEVIN KROCK, CHETAN PUJARA
  • Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
    Patent number: 8691802
    Abstract: Citric acid and conjugate bases thereof are useful for stabilizing stabilized chlorine dioxide in the presence of therapeutically active agents and excipients in a composition. Ophthalmic compositions and methods related thereto are also disclosed herein.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: April 8, 2014
    Assignee: Allergan, Inc.
    Inventors: Robert T. Lyons, Robert S. Jordan
  • Artificial tears and therapeutic uses
    Patent number: 8679554
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e. g. olive oil, sesame oil, corn oil etc.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: March 25, 2014
    Assignee: Allergan, Inc.
    Inventors: Anuradha V. Gore, Robert S. Jordan, Kevin Krock, Chetan Pujara
  • ARTIFICIAL TEARS AND THERAPEUTIC USES
    Publication number: 20130295206
    Abstract: The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e. g. olive oil, sesame oil, corn oil etc.
    Type: Application
    Filed: June 28, 2013
    Publication date: November 7, 2013
    Inventors: ANURADHA V. GORE, ROBERT S. JORDAN, KEVIN KROCK, CHETAN PUJARA